ECG Event Recorder Market - Growth Drivers and Challenges
Growth Drivers
- Shift toward ambulatory and remote monitoring: The transition of the healthcare industry to value-based care is prompting wide adoption of remote patient monitoring (RPM). The products available in the ECG event recorder market, particularly wearable devices, allow patients to collect continuous rhythm data conveniently and affordably without requiring hospital stays, improving patient compliance. Besides, the emergence of telemedicine services, particularly after the pandemic, further accelerates the pace of this shift. Moreover, this movement toward decentralized cardiac care continues to fuel growth in this sector.
- Growing awareness and early diagnosis campaigns: Governments and health organizations across the globe are increasingly participating in public awareness campaigns and cohorts to educate the maximum patient volume about the importance of early detection in managing severe heart conditions. Their efforts to promote regular screening, especially during Heart Month or World Heart Day, further push more people to consider adopting advanced tools from the market. As evidence, in 2024, the U.S. Preventive Services Task Force released new guidelines providing recognition to ECG abnormalities as the primary indicator of CVD events.
- Integration of next-generation data analytics: The market is evolving rapidly through the increasing use of AI for seamless analysis of large rhythm data. As evidence, in May 2024, Philips demonstrated promising results from the retrospective study at the Heart Rhythm Annual Meeting in Boston, solidifying the efficiency of its AI-powered cardiac care pipeline. As per this dataset, the company’s MCOT device lowered hospital readmission rates by 5.2% compared to implantable loop recorders, while reducing the average 18-month cost of stroke events by USD 27,429. These figures yield greater efficiency out of AI-based recorders, making them more valuable to providers.
Demographic Trends in Key Medical Disciplines in the ECG Event Recorder Market
Overview of the Global CVD Durden (2022)
|
CVD Type |
Number of Prevalent Cases |
Number of Death Cases |
Prevalence (per 100,000) |
Deaths (per 100,000) |
DALYs (per 100,000) |
|
Rheumatic heart disease |
46,358,651 |
386,947 |
575.5 |
4.5 |
162.5 |
|
Ischemic heart disease |
315,390,626 |
9,239,181 |
3,610.2 |
108.8 |
2,275.9 |
|
Ischemic stroke |
86,661,746 |
3,542,299 |
994.5 |
42.3 |
819.5 |
|
Intracerebral hemorrhage |
20,509,587 |
3,428,876 |
237.9 |
39.4 |
923.8 |
|
Subarachnoid hemorrhage |
9,281,913 |
344,872 |
107.2 |
4.0 |
120.7 |
|
Hypertensive heart disease |
13,052,641 |
1,353,074 |
150.9 |
16.1 |
292.7 |
|
Non-rheumatic calcific aortic valve disease |
13,551,699 |
146,199 |
156.6 |
1.8 |
26.8 |
|
Non-rheumatic degenerative mitral valve disease |
15,592,046 |
37,843 |
177.9 |
|
11.1 |
|
Other non-rheumatic valve diseases |
12,130 |
2,033 |
0.1 |
<0.1 |
0.6 |
|
Myocarditis |
625,129 |
26,702 |
7.8 |
0.3 |
11.8 |
|
Alcoholic cardiomyopathy |
|
62,661 |
6.3 |
0.7 |
24.6 |
|
Other cardiomyopathy |
4,715,332 |
295,751 |
58.7 |
3.5 |
99.3 |
|
Pulmonary arterial hypertension |
193,710 |
20,561 |
2.3 |
0.2 |
7.4 |
|
Atrial fibrillation and flutter |
55,414,434 |
362,381 |
|
4.5 |
102.9 |
|
Lower extremity peripheral arterial disease |
105,980,247 |
73,928 |
1,213.3 |
0.9 |
19.6 |
|
Endocarditis |
438,374 |
82,402 |
5.4 |
1.0 |
25.8 |
|
Other cardiovascular and circulatory diseases |
86,722,785 |
221,797 |
1,006.1 |
2.6 |
118.8 |
Source: NLM
Challenges
- Pricing constraints and reimbursement limitations: Governments and insurance companies frequently impose price limits and strict reimbursement guidelines. This move favored local manufacturers, giving them a competitive edge over international companies. Dealing with various regulatory environments also becomes time-consuming and expensive due to their differing criteria. Thus, despite being a great favor to local manufacturers, these factors remain a hurdle for global companies seeking globalization.
ECG Event Recorder Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
8.1% |
|
Base Year Market Size (2025) |
USD 1.7 billion |
|
Forecast Year Market Size (2035) |
USD 3.4 billion |
|
Regional Scope |
|